arg-pro-hyp-gly-thi-ser-phe-thi-arg tfa has been researched along with Goldblatt Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benetos, A; Gavras, H; Gavras, I; Hatinoglou, S; Stewart, JM; Vavrek, R | 1 |
| Benetos, A; Gavras, H; Gavras, I; Hatinoglou, S; Stewart, JM; Vavrek, RJ | 1 |
2 other study(ies) available for arg-pro-hyp-gly-thi-ser-phe-thi-arg tfa and Goldblatt Syndrome
| Article | Year |
|---|---|
The antihypertensive contribution of bradykinin as assessed by a specific bradykinin antagonist.
Topics: Animals; Antihypertensive Agents; Bradykinin; Enalapril; Fluoroacetates; Hypertension, Renovascular; Male; Nitroprusside; Oligopeptides; Rats; Rats, Inbred Strains; Saralasin | 1987 |
Vasodepressor role of endogenous bradykinin assessed by a bradykinin antagonist.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Enalapril; Fluoroacetates; Hypertension, Renovascular; Male; Nitroprusside; Oligopeptides; Rats; Rats, Inbred Strains; Saralasin | 1986 |